Trials / Withdrawn
WithdrawnNCT01851486
The Relationships Between the Noradrenergic, Opioid and Pain System
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The role of alpha2 receptor agonist on pain perception and modulation will be examined. In addition whether this is mediated through the opioid system will be examined. Pain perception and modulation will be examined before and after administration of Clonidine or placebo together with Naloxone or saline.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clonidine | Clonidine 0.15 mg |
| DRUG | Naloxone | naloxone 0.15 mg/kg |
| DRUG | placebo | |
| OTHER | saline |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2013-05-10
- Last updated
- 2017-10-04
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01851486. Inclusion in this directory is not an endorsement.